{"id":2296,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2005-10-06","marketCap":353.536,"name":"Altimmune Inc","phone":"12406541450.0","outstanding":53.73,"symbol":"ALT","website":"https://altimmune.com/","industry":"Biotechnology"},"price":7.332375,"year":2023,"month":12,"day":16,"weekday":"Saturday","title":"Historical Stock Splits and Corporate Actions of Altimmune Inc","date":"2023-12-16","url":"/posts/2023/12/16/ALT","content":[{"section":"2015","text":"Altimmune Inc is founded."},{"section":"2016","text":"Altimmune completes a reverse merger with Vaxin Inc, acquiring their technology and pipeline."},{"section":"2017","text":"Altimmune acquires Spun Assets, a biopharmaceutical company focused on animal health products."},{"section":"2018","text":"Altimmune announces a 1-for-10 reverse stock split, reducing the number of outstanding shares."},{"section":"2020","text":"Altimmune receives a $4.7 million grant from the Bill \u0026 Melinda Gates Foundation to support the development of a single-dose, temperature-stable COVID-19 vaccine candidate."},{"section":"2021","text":"Altimmune enters into a collaboration agreement with Dynavax Technologies to develop a next-generation COVID-19 vaccine utilizing both companies' technologies."},{"section":"2022","text":"Altimmune announces a 1-for-5 reverse stock split, further consolidating the outstanding shares."},{"section":"2023","text":"Altimmune successfully completes a Phase 2 clinical trial for its HepTcell program, showing positive results in the treatment of chronic hepatitis B infection."}],"tags":["CrossOver55","Long","Biotechnology"],"news":[{"category":"company","date":1702370460,"headline":"Clean Earth and Alternus Energy Announce Continuation of Business Combination Close Process","id":124468751,"image":"","symbol":"ALT","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=99n1z4vsmn"},{"category":"company","date":1702036440,"headline":"Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet","id":124397379,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3248087727"},{"category":"company","date":1702033500,"headline":"Altimmune call volume above normal and directionally bullish","id":124397474,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3248026310"},{"category":"company","date":1702033380,"headline":"$1000 Invested In Altimmune 5 Years Ago Would Be Worth This Much Today","id":124397475,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3248024209"},{"category":"company","date":1702024800,"headline":"Unusually active option classes on open December 8th","id":124391671,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3247851486"},{"category":"company","date":1702024500,"headline":"Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing","id":124390594,"image":"","symbol":"ALT","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=p387m5xpm1"},{"category":"company","date":1702005180,"headline":"Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'","id":124412130,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3248347773"},{"category":"company","date":1702000980,"headline":"Catalyst Watch: Intel's AI event, Oracle earnings and CAVA IPO lockup expiration","id":124396360,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3248254483"},{"category":"company","date":1701952380,"headline":"Altimmune's stock pops as analysts see obesity-drug partnership potential","id":124375158,"image":"https://images.mktw.net/im-520633/social","symbol":"ALT","publisher":"MarketWatch","summary":"Altimmune shares have jumped this week as analysts see potential for the company to find a partner for its experimental weight-loss drug.","url":"https://www.marketwatch.com/story/altimmune-shares-pop-as-analysts-see-obesity-drug-partnership-potential-524ea4f4"},{"category":"company","date":1701951300,"headline":"Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":124364215,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246254507"},{"category":"company","date":1701949140,"headline":"Altimmuneâ€™s stock pops as analysts see obesity-drug partnership potential","id":124372648,"image":"","symbol":"ALT","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246200316"},{"category":"company","date":1701948840,"headline":"Altimmune shares pop as analysts see obesity-drug partnership potential","id":124372649,"image":"","symbol":"ALT","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246193992"},{"category":"company","date":1701940740,"headline":"Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday","id":124360579,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246010563"},{"category":"company","date":1701935100,"headline":"Largest borrow rate increases among liquid names","id":124360145,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245891277"},{"category":"company","date":1701863040,"headline":"ALT, SYRS and PHIO among mid-day movers","id":124336953,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244330252"},{"category":"company","date":1701862380,"headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","id":124338947,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244316922"},{"category":"company","date":1701858600,"headline":"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities","id":124335404,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244227464"},{"category":"company","date":1701852561,"headline":"Altimmune: Don't Buy The GLP-1 Move-Up","id":124330152,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1584964652/image_1584964652.jpg?io=getty-c-w1536","symbol":"ALT","publisher":"SeekingAlpha","summary":"Altimmune's recent MOMENTUM data is not as strong as it seems. Read more to see an overview and analysis of ALT stock.","url":"https://seekingalpha.com/article/4656289-altimmune-dont-buy-the-glp-1-move-up"},{"category":"company","date":1701852000,"headline":"Unusually active option classes on open December 6th","id":124333043,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244076262"},{"category":"company","date":1701848820,"headline":"Altimmune price target raised to $15 from $8 at B. Riley","id":124347516,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244009456"},{"category":"company","date":1701848280,"headline":"TGTX, IBIO and ALT are among pre market gainers","id":124332343,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3243997053"},{"category":"company","date":1701841109,"headline":"Altimmune: Pemvidutide Data Reinforces Obesity Drug Outlook","id":124328476,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1816294395/image_1816294395.jpg?io=getty-c-w1536","symbol":"ALT","publisher":"SeekingAlpha","summary":"Altimmune has made a good amount of progress in being able to advance pemvidutide for the treatment of patients with obesity and NASH. Find out why ALT stock is a Buy.","url":"https://seekingalpha.com/article/4656263-altimmune-pemvidutide-data-reinforces-obesity-drug-outlook"},{"category":"company","date":1701836104,"headline":"PRISM MarketView Highlights Altimmune's Positive Topline Results in Obesity Drug Trial","id":124327792,"image":"","symbol":"ALT","publisher":"Finnhub","summary":"New York, N.Y. - PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Altimmune, Inc. which has reported positive topline results from its 48-week MOMENTUM...","url":"https://finnhub.io/api/news?id=13bce13cfd93f6c0cef5c2cda65734fccfed07ff5b56e58dd8fd174b60db1d8c"},{"category":"company","date":1701834240,"headline":"ALT, CONN and VRNT are among after hour movers","id":124343960,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244695865"},{"category":"company","date":1701827220,"headline":"Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session","id":124339785,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244515708"},{"category":"company","date":1701782354,"headline":"Altimmune open to partnerships, deals with drugmakers, says CEO","id":124308107,"image":"","symbol":"ALT","publisher":"Finnhub","summary":"Weight-loss drug developer Altimmuneis open to deals and collaborations with largedrugmakers as it actively looks for partners to launch anddevelop its experimental obesity drug, CEO Vipin Garg...","url":"https://finnhub.io/api/news?id=587c9c2a39382d235a029e7993ebd4000a479795fc519d6768dbd3d18999a84f"},{"category":"company","date":1701774540,"headline":"While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer","id":124309778,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242421421"},{"category":"company","date":1701763740,"headline":"Top 5 Health Care Stocks That Are Ticking Portfolio Bombs","id":124303397,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242187858"},{"category":"company","date":1701692220,"headline":"Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session","id":124281652,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240772662"},{"category":"company","date":1701689700,"headline":"12 Health Care Stocks Moving In Monday's Intraday Session","id":124282819,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240716655"},{"category":"company","date":1701687540,"headline":"Viking Therapeutics rises on Roche acquiring peer Carmot","id":124279780,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240667732"},{"category":"company","date":1701685500,"headline":"Weight-loss drug developers rise after Roche agrees to buy Carmot","id":124279739,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240625716"},{"category":"company","date":1701684480,"headline":"Biotech Alert: Searches spiking for these stocks today","id":124283362,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240604843"},{"category":"company","date":1701678900,"headline":"Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023","id":124279195,"image":"","symbol":"ALT","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=m9447vbwl9"},{"category":"company","date":1701677640,"headline":"Altimmune price target raised to $16 from $10 at Guggenheim","id":124291549,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240468603"},{"category":"company","date":1701672060,"headline":"Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and Atricure (ATRC)","id":124287406,"image":"","symbol":"ALT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240373510"},{"category":"company","date":1701665460,"headline":"Roche ventures into weight-loss drug market with $2.7B buyout of Carmot","id":124279786,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240283316"},{"category":"company","date":1701660180,"headline":"Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market","id":124291552,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3241026254"}]}